Loading organizations...
Loading organizations...
Drug and target discovery using AI and synthetic biology.
Absci has raised $32.5M across 3 funding rounds.
Absci has raised $32.5M in total across 3 funding rounds.
Absci has raised $32.5M in total across 3 funding rounds.
Absci's investors include JSR Life Sciences, KBI Biopharma, Columbia Ventures Corporation, Oregon Venture Fund, Phoenix Venture Partners, WRF Capital, Gustavo Mahler, GreenBridge, Zach Jonasson, VentureSouth.
Absci has raised $32.5M across 3 funding rounds. Most recently, it raised $15.4M Debt / Series D in January 2020.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Jan 14, 2020 | $15.4M Debt / Series D | JSR Life Sciences, KBI Biopharma | Columbia Ventures Corporation, Oregon Venture Fund, Phoenix Venture Partners, WRF Capital |
| May 30, 2018 | $12.0M Series C | Gustavo Mahler | Columbia Ventures Corporation, GreenBridge, Oregon Venture Fund, Zach Jonasson, VentureSouth, WRF Capital |
| Apr 25, 2016 | $5.1M Series A | Zach Jonasson |